The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 06, 2018

Filed:

Jan. 23, 2007
Applicants:

Robert Mays, Cleveland Heights, OH (US);

Robert J. Deans, Riverside, CA (US);

David C. Hess, Martinez, GA (US);

James E. Carroll, Augusta, GA (US);

Cesar V. Borlongan, Tampa, FL (US);

Inventors:

Robert Mays, Cleveland Heights, OH (US);

Robert J. Deans, Riverside, CA (US);

David C. Hess, Martinez, GA (US);

James E. Carroll, Augusta, GA (US);

Cesar V. Borlongan, Tampa, FL (US);

Assignees:

ATHERSYS, INC., Cleveland, OH (US);

Augusta University Research Institute, Inc., Augusta, GA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 35/51 (2015.01); A61K 35/545 (2015.01); A61K 31/4353 (2006.01); A61K 31/436 (2006.01); A61K 31/485 (2006.01); A61K 31/52 (2006.01); A61K 31/661 (2006.01); A61K 35/12 (2015.01); A61K 35/28 (2015.01); A61K 35/30 (2015.01); A61K 35/407 (2015.01); A61K 35/44 (2015.01); A61K 35/48 (2015.01); A61K 38/13 (2006.01);
U.S. Cl.
CPC ...
A61K 35/50 (2013.01); A61K 31/436 (2013.01); A61K 31/4353 (2013.01); A61K 31/485 (2013.01); A61K 31/52 (2013.01); A61K 31/661 (2013.01); A61K 35/12 (2013.01); A61K 35/28 (2013.01); A61K 35/30 (2013.01); A61K 35/407 (2013.01); A61K 35/44 (2013.01); A61K 35/48 (2013.01); A61K 35/51 (2013.01); A61K 35/545 (2013.01); A61K 38/13 (2013.01);
Abstract

The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.


Find Patent Forward Citations

Loading…